Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Nimenrix A Group	311
Overall Study	STARTED	Nimenrix B Group	311
Overall Study	STARTED	Nimenrix C Group	313
Overall Study	STARTED	Mencevax ACWY Group	312
Overall Study	STARTED	Nimenrix+Fluarix Group	105
Overall Study	COMPLETED	Nimenrix A Group	305
Overall Study	COMPLETED	Nimenrix B Group	306
Overall Study	COMPLETED	Nimenrix C Group	307
Overall Study	COMPLETED	Mencevax ACWY Group	310
Overall Study	COMPLETED	Nimenrix+Fluarix Group	105
Overall Study	NOT COMPLETED	Nimenrix A Group	6
Overall Study	NOT COMPLETED	Nimenrix B Group	5
Overall Study	NOT COMPLETED	Nimenrix C Group	6
Overall Study	NOT COMPLETED	Mencevax ACWY Group	2
Overall Study	NOT COMPLETED	Nimenrix+Fluarix Group	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00453986/flow